Lv5
1428 积分 2021-01-28 加入
Discovery of Naphthyridinone Derivatives as Selective PKMYT1/WEE1 Dual Inhibitors for Cancer Therapy
25天前
已完结
What Happens in Successful Optimizations? A Survey of 2018–2024 Literature
26天前
已完结
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients With MTAP-Deleted Cancers
1个月前
已完结
Drug screening approaches for small-molecule compounds in cancer-targeted therapy
1个月前
已完结
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
1个月前
已完结
Payload-dependent photostability of antibody-drug conjugates
1个月前
已完结
Antibody–drug conjugates: Recent advances in payloads
1个月前
已完结
Dual-payload antibody–drug conjugates: Taking a dual shot
1个月前
已完结
XMT-2056, a HER2-Directed STING Agonist Antibody–Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells
1个月前
已完结
When will the immune-stimulating antibody conjugates (ISACs) be transferred from bench to bedside?
1个月前
已完结
皖公网安备34019202002308
